iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sets New 12-Month High – Here’s Why

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)’s stock price hit a new 52-week high on Tuesday . The stock traded as high as $91.64 and last traded at $91.66, with a volume of 4062 shares changing hands. The stock had previously closed at $91.07.

iShares U.S. Pharmaceuticals ETF Stock Performance

The company has a market capitalization of $1.03 billion, a P/E ratio of 17.75 and a beta of 0.54. The company has a 50-day simple moving average of $87.05 and a 200 day simple moving average of $79.42.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in IHE. Hudock Inc. boosted its stake in iShares U.S. Pharmaceuticals ETF by 3.9% in the fourth quarter. Hudock Inc. now owns 3,034 shares of the company’s stock worth $257,000 after purchasing an additional 114 shares in the last quarter. O Shaughnessy Asset Management LLC raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 35.0% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock valued at $39,000 after buying an additional 120 shares during the last quarter. National Bank of Canada FI lifted its position in iShares U.S. Pharmaceuticals ETF by 42.7% during the 3rd quarter. National Bank of Canada FI now owns 585 shares of the company’s stock worth $42,000 after buying an additional 175 shares in the last quarter. Corient Private Wealth LLC grew its holdings in iShares U.S. Pharmaceuticals ETF by 3.1% during the 4th quarter. Corient Private Wealth LLC now owns 6,506 shares of the company’s stock worth $552,000 after acquiring an additional 198 shares during the last quarter. Finally, NBC Securities Inc. increased its position in iShares U.S. Pharmaceuticals ETF by 46.5% in the 4th quarter. NBC Securities Inc. now owns 630 shares of the company’s stock valued at $53,000 after acquiring an additional 200 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.